Thailand discovered a total of 4,000 daily Covid-19 infections with 22 additional deaths in the past 24 hours, the Center for Covid-19 Situation Administration (CCSA) reported today, December 6th.
The fatalities were 13 men and 9 women with the most numbers recorded in Chonburi with 3. 20 of them were Thai nationals and one of each was a Myanmar and Chinese national. The age range was between 41 and 101 years old.
Most of them were reported with underlying health conditions, including hypertension (12), diabetes (5), hyperlipidemia (5), obesity (2), and kidney disease (2).
Of the new cases, 3,811 were found in hospitals and medical services (which includes contact tracing cases), 155 were from a proactive approach at previously reported clusters, 27 were from prisons, and the remaining 7 were imported cases.
A number of 69,010 patients are still under treatment/isolation/medical care. Of that, 1,259 patients are in critical condition including 330 on ventilators. This is roughly 1.82 percent of cases that are critical while 26.2 percent of that is critical enough for a ventilator.
Regarding the non-prison local infections, the highest number of patients were reported in Bangkok with 782, followed by Nakhon Sri Thammarat with 333, Songkhla with 221, Chonburi with 150, Surat Thani with 144, and Pattani with 108.
A total number of 186,386 people nationwide have received Covid-19 vaccines in the past 24 hours. Of that, 93,601 people had received their first shots, 54,303 people had received their second shots, and 38,432 people had received their third shots. This is roughly 68.3% of the total Thai population who have had their first shot of a Covid-19 vaccine, 59.0% who have had a second shot and are fully vaccinated, and 5.2% have had a third booster shot.
As of today, 6,450 people fully recovered in the past 24 hours and have been released from field hospitals and quarantine centers. Thailand has now reached a total of 2,145,241 cases with 2,055,265 recoveries and a total of 20,966 deaths since the start of the pandemic.
Follow us on Facebook